Introduction: Tumors of the salivary glands are relatively rare, comprising slightly less than 3 per 
cent of all head and neck neoplasms. Parotid tumors are the most common salivary glands tumours.
Their relative infrequency and tendency to histological variability continue to contribute to a grave 
lack of hard data on which to pursue an ‘evidence-based approach' to the subject. Aim of the Work: 
This study aims to appraise the literature and write an updated review about parotid neoplasms and 
the new concepts of relation and comparison between preoperative diagnosis by different 
investigational methods and postoperative pathological analysis and also approaches in their surgical 
management. Patients and Methods: Patients enrolled in this study were scheduled for 
parotidectomy. The number of patients included in this study were forty-six patients. The study is a 
retrospective study of the patients presenting to National Cancer Institute (NCI) in 2019 with parotid 
tumors. Results: This study was performed in National Cancer Institute (NCI) between January 2019 
and December 2019. Forty-six patients with Parotid neoplasm who underwent parotidectomy were 
included in this study. Conclusion: The epidemiology, diagnosis and management of parotid tumors 
has changed in the past two- or three-decades giving rise to new risk factors, pre-operative diagnostic 
techniques and novel approaches to surgery with new surgical procedures. The better understanding to 
the pathological behavior and the introduction of new advances in radiotherapy led to better control of 
locoregional malignant parotid tumors. New approaches to surgery and better cosmetic results made 
parotid surgery a less complicating one where patients with an early disease can have a curative 
surgery with almost no apparent scar or disfigurement.